Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 millionZealand Pharma to acquire insulin pump maker Valeritas for USD 23 million
    Roche Alzheimers disease drug fails to meet primary goalRoche Alzheimers disease drug fails to meet primary goal
    Nestle invests $200 million more in Aimmune after peanut allergy drug approvalNestle invests $200 million more in Aimmune after peanut allergy drug approval
    JB Chemicals Gujarat unit passes USFDA inspection with one observationJB Chemicals Gujarat unit passes USFDA inspection with one observation
    Coronavirus in China cause of concern for Indian Pharma SectorCoronavirus in China cause of concern for Indian Pharma Sector
    Cipla acquires 4 key brands from Wanbury for up to Rs 89 croreCipla acquires 4 key brands from Wanbury for up to Rs 89 crore
    Cipla acquires 4 nutrition products from Wanbury for Rs 89 croreCipla acquires 4 nutrition products from Wanbury for Rs 89 crore
    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademarkBevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark
    FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: GovernmentFDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government
    Dr Reddys launches generic version of Syprine in USDr Reddys launches generic version of Syprine in US
    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 croreReligare Enterprises to divest stake in arm to Kedaara for Rs 200 crore
    Pfizer Oncology biosimilar Ruxience gets positive opinion from CHMPPfizer Oncology biosimilar Ruxience gets positive opinion from CHMP
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    MSD India appoints Rehan A Khan as Managing Director

    MSD India appoints Rehan A Khan as Managing Director

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok